Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-16-019562
Filing Date
2016-09-14
Accepted
2016-09-14 13:34:51
Documents
1
Period of Report
2016-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_147387447815185.html 4  
1 FORM 4 wf-form4_147387447815185.xml 4 10023
  Complete submission text file 0001628280-16-019562.txt   11700
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 702 OGDEN AVE TEANECK NJ 07666
Business Address
MILLER DAVID BARRY (Reporting) CIK: 0001578847 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11504 | Film No.: 161884785